Cargando…
肺腺癌靶向治疗后小细胞肺癌转化的病例报道
In recent years, the chemotherapy of non-small cell lung cancer (NSCLC) has almost been reached a platform stage, and there is no obvious progress in terms of response rate (RR) and overall survival (OS); With the great development of molecular biology, epidermal growth factor receptor-tyrosine kina...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000092/ https://www.ncbi.nlm.nih.gov/pubmed/26483340 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.10 |